Tag: Eteplirsen

Tag Visualization: Top 50 related tags by occurrence

Recent Related Articles to Eteplirsen

Baird Has Just Reaffirmed $202 Target Price Per Share on Sarepta Therapeutics (NASDAQ:SRPT ...

Added to Collection on: 2018-06-21 18:07:30

Tags for this article:

NASDAQ
Economy of the United States
Biology
Biotechnology
Sarepta Therapeutics
Eteplirsen

Click the tags to see associated articles and topics

View Article Details
How Many Sarepta Therapeutics, Inc. (NASDAQ:SRPT)'s Analysts Are Bullish?

Added to Collection on: 2018-07-01 19:03:19

Tags for this article:

Money
Finance
Economy
NASDAQ
Short
Sarepta Therapeutics
Old Sarepta
Eteplirsen

Click the tags to see associated articles and topics

View Article Details
Two Artificial Intelligence Companies Partner to Take on DMD and Orphan Diseases

Added to Collection on: 2018-07-22 12:07:30

Tags for this article:

Health
Biology
Biotechnology
Drug discovery
Insilico Medicine
Muscular dystrophy
Eteplirsen
Dystrophin
Ezutromid

Click the tags to see associated articles and topics

View Article Details
Sarepta Therapeutics (SRPT) Posts Earnings Results

Added to Collection on: 2019-05-10 00:41:15

Tags for this article:

Life Sciences
Biotechnology
Antisense RNA
Muscular dystrophy
Therapeutic gene modulation
Biology
Corvallis, Oregon
Sarepta Therapeutics
Stock market
Eteplirsen
Golodirsen
Stock
Sarepta Therapeutics Inc.

Click the tags to see associated articles and topics

View Article Details
Sarepta Therapeutics, Inc. (NASDAQ:SRPT) Given Consensus Rating of "Buy" by Brokerages

Added to Collection on: 2020-11-23 14:48:45

Tags for this article:

Antisense RNA
Muscular dystrophy
Therapeutic gene modulation
Life Sciences
Biotechnology
Corvallis, Oregon
Sarepta Therapeutics
Golodirsen
Financial economics
Eteplirsen
Sarepta
Stock
Sarepta Therapeutics Inc.

Click the tags to see associated articles and topics

View Article Details
Here's Why Sarepta Therapeutics Lost Support on Wall Street

Added to Collection on: 2021-01-10 12:56:15

Tags for this article:

Muscular dystrophy
Branches of biology
Life Sciences
Biotechnology
Golodirsen
Sarepta Therapeutics
Eteplirsen
Duchenne muscular dystrophy
Dystrophin
Ezutromid

Click the tags to see associated articles and topics

View Article Details
The stakes for choosing the right FDA commissioner couldn't be higher

Added to Collection on: 2021-01-24 12:00:00

Tags for this article:

Food and Drug Administration
Healthcare in the United States
United States Department of Health and Human Services
Health in the United States
Joshua Sharfstein
Margaret Hamburg
Janet Woodcock
Sarepta Therapeutics
Eteplirsen
Stephen Hahn
Center for Drug Evaluation and Research
Draft:Home HIV Test
Joe Biden

Click the tags to see associated articles and topics

View Article Details
Biopharma Closely Watching Biden's Pick For The Next FDA Commissioner – With Biogen Having ...

Added to Collection on: 2021-02-24 21:33:45

Tags for this article:

Life Sciences
Drugs
Biotechnology
Aducanumab
Biogen
Janet Woodcock
Joshua Sharfstein
Eteplirsen
Sharfstein
Troglitazone

Click the tags to see associated articles and topics

View Article Details
FDA Panel Member Tells Healthline Why He Resigned Over Alzheimer's Drug Approval

Added to Collection on: 2021-07-02 10:16:53

Tags for this article:

Muscular dystrophy
Food and Drug Administration
Aducanumab
Alzheimer's disease
Treatment of Alzheimer's disease
Eteplirsen
Drisapersen
Life Sciences
Health
Aaron S. Kesselheim

Click the tags to see associated articles and topics

View Article Details
Roche dives deeper into gene therapy with $1.15 billion Sarepta licensing deal

Added to Collection on: 2024-05-14 21:05:06

Tags for this article:

Muscular dystrophy
Antisense RNA
Therapeutic gene modulation
Biotechnology
Corvallis, Oregon
Sarepta Therapeutics
Roche
Gene therapy
Eteplirsen
Duchenne muscular dystrophy
Therapy
Astellas Pharma
United States
Sarepta Therapeutics Inc.

Click the tags to see associated articles and topics

View Article Details
Book a Demo